CMMB vs TYL · $22.2M cap vs P/E 89, rev $1.26B
Chemomab Therapeutics Ltd DRC (CMMB) versus Tyler Technologies Inc (TYL) — a side-by-side from cached financials, not a winner call.
Chemomab Therapeutics Ltd DRC (CMMB) is a biotechnology company listed on US.
Tyler Technologies Inc (TYL) is a software - application company listed on US.
CMMB does not have a complete income-statement cache yet.
Latest reported TYL revenue for 2026-06-30 was $1.26B. Net income was $174.7M. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
CMMB currently screens at market cap $22.2M. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
Not investment advice. Open the CMMB and TYL stock pages for the full models.
Not investment advice.